Project Description
As Johnson & Johnson’s Janssen division developed its go-to-market strategy for INVOKANA, its first entrant in the crowded Type 2 Diabetes category, they knew they were in for a dogfight.
The brand would need to clearly articulate the benefits of its first-in-new-class position to challenge the massive legacy brands that long dominated the category.Client
Invokana